Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Drug Administration of Tafenoquine for P. Vivax Radical Cure
NCT06575647Phase 4Completed
- Sponsor
- Shoklo Malaria Research Unit
- Start
- Feb 2025
- Primary completion
- Oct 2025
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tafenoquine in malaria, sponsored by Shoklo Malaria Research Unit. Started Feb 2025; status: completed.
02
Drugs
tafenoquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT06575647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06575647.